These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3104214)

  • 1. Role of MHC class-I antigens and the CD3 complex in the lysis of autologous human tumours by T-cell clones.
    Roberts TE; Shipton U; Moore M
    Int J Cancer; 1987 Apr; 39(4):436-41. PubMed ID: 3104214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma cell lysis by human CTL clones: differential involvement of T3, T8 and HLA antigens.
    Fossati G; Anichini A; Parmiani G
    Int J Cancer; 1987 Jun; 39(6):689-94. PubMed ID: 3108167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
    Aparicio P; Jaraquemada D; López de Castro JA
    J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.
    Anichini A; Fossati G; Parmiani G
    Int J Cancer; 1985 May; 35(5):683-9. PubMed ID: 3158614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
    Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell clones that react against autologous human tumors.
    Mukherji B; Chakraborty NG; Sivanandham M
    Immunol Rev; 1990 Aug; 116():33-62. PubMed ID: 2146210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic human HLA class II restricted purified protein derivative-reactive T-lymphocyte clones. IV. Analysis of HLA restriction pattern and mycobacterial antigen specificity.
    Hansen PW; Petersen CM; Povlsen JV; Kristensen T
    Scand J Immunol; 1987 Mar; 25(3):295-303. PubMed ID: 3494302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.
    Meuer SC; Schlossman SF; Reinherz EL
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4395-9. PubMed ID: 6981813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
    Slovin SF; Lackman RD; Ferrone S; Kiely PE; Mastrangelo MJ
    J Immunol; 1986 Nov; 137(9):3042-8. PubMed ID: 3093588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity.
    David V; Bourge JF; Guglielmi P; Mathieu-Mahul D; Degos L; Bensussan A
    J Immunol; 1987 May; 138(9):2831-6. PubMed ID: 3106490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auto-tumor immunity in patients with solid tumors: participation of CD3 complex and MHC class I antigens in the lytic interaction.
    Vánky F; Roberts T; Klein E; Willems J
    Immunol Lett; 1987 Oct; 16(1):21-6. PubMed ID: 3501402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
    Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
    Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP; DeMars R; Hank JA; Sondel PM
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.